These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36105612)
1. Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis. Afief AR; Irham LM; Adikusuma W; Perwitasari DA; Brahmadhi A; Chong R Biochem Biophys Rep; 2022 Dec; 32():101337. PubMed ID: 36105612 [TBL] [Abstract][Full Text] [Related]
2. Integration of genetic variants and gene network for drug repurposing in colorectal cancer. Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641 [TBL] [Abstract][Full Text] [Related]
3. Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information. Adikusuma W; Irham LM; Chou WH; Wong HS; Mugiyanto E; Ting J; Perwitasari DA; Chang WP; Chang WC Front Immunol; 2021; 12():724277. PubMed ID: 34721386 [TBL] [Abstract][Full Text] [Related]
4. Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach. Irham LM; Adikusuma W; Perwitasari DA Biochem Biophys Rep; 2022 Dec; 32():101334. PubMed ID: 36090591 [TBL] [Abstract][Full Text] [Related]
5. The use of genomic variants to drive drug repurposing for chronic hepatitis B. Irham LM; Adikusuma W; Perwitasari DA; Dania H; Maliza R; Faridah IN; Santri IN; Phiri YVA; Chong R Biochem Biophys Rep; 2022 Sep; 31():101307. PubMed ID: 35832745 [TBL] [Abstract][Full Text] [Related]
6. Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis. Adikusuma W; Chou WH; Lin MR; Ting J; Irham LM; Perwitasari DA; Chang WP; Chang WC Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052792 [TBL] [Abstract][Full Text] [Related]
7. Integrated genomic analysis to identify druggable targets for pancreatic cancer. Mugiyanto E; Adikusuma W; Irham LM; Huang WC; Chang WC; Kuo CN Front Oncol; 2022; 12():989077. PubMed ID: 36531045 [TBL] [Abstract][Full Text] [Related]
8. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies. Xu Y; Kong J; Hu P Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354 [No Abstract] [Full Text] [Related]
9. Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data. Wang X; Wang Y; Zhang X; Hong X; Rang X; Yang D; Huang S; Xu C; Fu J Mult Scler Relat Disord; 2023 Oct; 78():104903. PubMed ID: 37556937 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis. Zazuli Z; Irham LM; Adikusuma W; Sari NM Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559013 [TBL] [Abstract][Full Text] [Related]
11. Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants. Lesmana MHS; Le NQK; Chiu WC; Chung KH; Wang CY; Irham LM; Chung MH Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009493 [TBL] [Abstract][Full Text] [Related]
12. The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren's Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data. Hong X; Wang X; Rang X; Yin X; Zhang X; Wang R; Wang D; Zhao T; Fu J Front Immunol; 2022; 13():857014. PubMed ID: 35356004 [TBL] [Abstract][Full Text] [Related]
13. Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms. Shepard CJ; Cline SG; Hinds D; Jahanbakhsh S; Prokop JW Physiol Genomics; 2019 Nov; 51(11):562-577. PubMed ID: 31482761 [TBL] [Abstract][Full Text] [Related]
14. Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning. Olla S; Steri M; Formato A; Whalen MB; Corbisiero S; Agresti C Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959343 [TBL] [Abstract][Full Text] [Related]
15. Understanding the role of corneal biomechanics-associated genetic variants by bioinformatic analyses. Sun X; Gao X; Mu BK; Wang Y Int Ophthalmol; 2022 Mar; 42(3):981-988. PubMed ID: 34642840 [TBL] [Abstract][Full Text] [Related]
16. Deciphering crucial genes in multiple sclerosis pathogenesis and drug repurposing: A systems biology approach. Dadashkhan S; Mirmotalebisohi SA; Poursheykhi H; Sameni M; Ghani S; Abbasi M; Kalantari S; Zali H J Proteomics; 2023 May; 280():104890. PubMed ID: 36966969 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach. Advani D; Kumar P ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679 [TBL] [Abstract][Full Text] [Related]
18. Identification of common susceptibility genes and drug target genes in multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis and its value to guide clinical treatment. Liu Y; Rang X; Zou X; Wang X; Zhang X; Wang Y; Xu C; Fu J Mult Scler Relat Disord; 2022 Feb; 58():103504. PubMed ID: 35030369 [TBL] [Abstract][Full Text] [Related]